Northern Trust »

Carmell Therapeutics Corp - US shares owned by Northern Trust

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Northern Trust from 13F filings

Historical chart of Northern Trust investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Northern Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Northern Trust

Quarter filed Position value Share count Share price at filing
2024-09-30 $21k 53k 0.40
2024-03-31 $138k 54k 2.56
2023-09-30 $84k 23k 3.60

More positions owned by Northern Trust

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Spdr S&p 500 Etf (SPY)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Berkshire Hathaway (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)

View all positions for Northern Trust

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Virtu Financial
Tower Research Capital
Morgan Stanley

View all funds holding Carmell Therapeutics Corp - US